Trial Profile
Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Sep 2015
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions; Therapeutic Use
- 25 Sep 2015 New trial record